Survival and tumor characteristics of German hereditary breast cancer patients

Breast Cancer Research and Treatment

Volumn 59, Issue 2, 2000, Pages 185-192

  Hamann, Ute ^a   Sinn, Hans Peter ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

BRCA1 mutation; Breast cancer; Disease free survival; Overall survival; Pathology

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; FAMILIAL CANCER; FEMALE; GENE MUTATION; GERMANY; HUMAN; MULTIVARIATE ANALYSIS; ONCOGENE; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ADULT; AGE OF ONSET; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POINT MUTATION; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0034091778     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006350518190     Document Type: Article

References (38)

1. 1. Casey G: The BRCA1 and BRCA2 breast cancer genes. Curr Opin Oncol 9: 88-93, 1997
2. 2. Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland: Krebs in Deutschland. Häufigkeiten und Trends. Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland (Hrsg), Saarbücken, 1997
3. 3. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71, 1994
4. 4. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62: 676-689, 1998
5. 5. Breast Cancer Information Core: http://www.nhgri.nih.gov/ Intramural_research/Lab_transfer/Bic, 1999
6. 6. Easton DF, Ford D, Bishop DT: Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56: 265-271, 1995
7. 7. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684-1689, 1990
8. 8. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE: Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343: 692-695, 1994
9. 9. Cornelis RS, Vasen HFA, Meijers-Heijboer H, Ford D, van Vliet M, van Tilborg AAG, Cleton FJ, Klijn JGM, Menko FH, Meera Khan P, Cornelisse CJ, Devilee P: Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer. Hum Genet 95: 539-544, 1995
10. 10. Jacquemier J, Eisinger F, Birnbaum D, Sobol H: Histoprognostic grade in BRCA1-associated breast cancer. Lancet 345: 1503, 1995
11. 11. Eisinger F, Stoppa-Lyonnet D, Longy M, Kerangueven F, Noguchi T, Bailly C, Vincent Salomon A, Jacquemier J, Birnbaum D, Sobol H: Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res 56: 471-474, 1996
12. 12. Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, Linder Stephenson L, Salerno G, Conway TA, Lynch HT: Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77: 697-709, 1996
13. 13. Sobol H, Stoppa-Lyonnet D, Bressac de Paillerets B, Peyrat JP, Kerangueven F, Janin N, Noguchi T, Eisinger F, Guinebretiere JM, Jacquemier J, Birnbaum D: Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers. Cancer Res 56: 3216-3219, 1996
14. 14. Breast Cancer Linkage Consortium: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 349: 1505-1510, 1997
15. 15. Johannsson OT, Idvall I, Anderson C, Borg A, Barkardottir RB, Egilsson V, Olsson H: Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur J Cancer 33: 362-371, 1997
16. 16. Robson M, Gilewski T, Haas B, Levin D, Borgen P, Rajan P, Hirschaut Y, Pressman P, Rosen PP, Lesser ML, Norton L, Offit K: BRCA-associated breast cancer in young women. J Clin Oncol 16: 1642-1649, 1998
17. 17. Verhoog LC, Brekelmans CT, Seynaeve C, van den Bosch LM, Dahmen G, van Geel AN, Tilanus-Linthorst MM, Bartels CC, Wagner A, van den Ouweland A, Devilee P, Meijers-Heijboer EJ, Klijn JG: Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 351: 316-321, 1998
18. 18. Porter DE, Cohen BB, Wallace MR, Smyth E, Chetty U, Dixon JM, Steel CM, Carter DC: Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br J Surg 81: 1512-1515, 1994
19. 19. Foulkes WD, Wong N, Brunet JS, Begin LR, Zhang JC, Martinez JJ, Rozen F, Tonin PN, Narod SA, Karp SE, Pollak MN: Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer. Clin Cancer Res 3: 2465-2469, 1997
20. 20. Foulkes WD, Wong N, Rozen F, Brunet JS, Narod SA: Survival of patients with breast cancer and BRCA1 mutations. Lancet 351: 1359-1360, 1998
21. 21. Johannsson OT, Ranstam J, Borg A, Olsson H: Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. J Clin Oncol 16: 397-404, 1998
22. 22. Lee JS, Wacholder S, Struewing JP, McAdams M, Pee D, Brody LC, Tucker MA, Hartge P: Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 91: 259-263, 1999
23. 23. Hamann U, Brauch H, Garvin AM, Bastert G, Scott RJ: German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene. Gen Chrom Cancer 18: 126-132, 1997
24. 24. Hamann U, Häner M, Stosiek U, Bastert G, Scott RJ: Low frequency of BRCA1 germline mutations in 45 German breast/ovarian cancer families. J Med Genet 34: 884-888, 1997
25. 25. Hamann U, Becher H, Zimmermann T, Pella K, Bastert G, Chang-Claude J: German family study on hereditary breast-ovarian cancer. J Med Genet 33: 633-635, 1996
26. 26. Chang-Claude J, Becher H, Eby N, Bastert G, Wahrendorf J, Hamann U: Modifying effect of reproductive risk factors on the age at onset of breast cancer for German BRCA1 mutation carriers. J Cancer Res Clin Oncol 123: 272-279, 1997
27. 27. Cox DR: Regression models and life tables. JR Statist Soc B 34: 187-220, 1972
28. 28. Brunet J-S, Narod SA, Tonin P, Foulkes WD: BRCA1 mutations and survival in women with ovarian cancer (letter; comment). N Engl J Med 336: 1256, 1997
29. 29. Rosen PP, Lesser ML, Kinne DW: Breast carcinoma at the extremes of age: a comparison of patients younger than 35 years and older than 75 years. J Surg Oncol 28: 90-96, 1985
30. 30. Kurtz JM, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D, Bressac C, Spitalier JM: Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol 8: 591-598, 1990
31. 31. Vanlemmens L, Hebbar M, Peyrat JP, Bonneterre J: Age as a prognostic factor in breast cancer. Anticancer Res 18: 1891-1896, 1998
32. 32. Feldman AL, Welch JP: Long-term outcome in women less than 30 years of age with breast cancer. J Surg Oncol 68: 193-198, 1998
33. 33. Marcus JN, Watson P, Page DL, Lynch HT: Pathology and heredity of breast cancer in younger women. Monogr Natl Cancer Inst 16: 23-34, 1994
34. 34. Fowble BL, Schultz DJ, Overmoyer B, Solin LJ, Fox K, Jardines L, Orel S, Glick JH: The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys 30: 23-33, 1994
35. 35. Albain KS, Allred DC, Clark GM: Breast cancer outcome and predictors of outcome: are there age differentials? Monogr Natl Cancer Inst 16: 35-42, 1994
36. 36. Sjogren S, Inganas M, Lindgren A, Holmberg L, Bergh J: Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers. J Clin Oncol 16: 462-69, 1998
37. 37. Ansquer Y, Gautier C, Fourquet A, Asselain B, Stoppa-Lyonnet D: Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group. Lancet 352: 541, 1998
38. 38. Burke W, Daly M, Garber J, Botkin J, Kahn MJ, Lynch P, McTiernan A, Offit K, Perlman J, Petersen G, Thomson E, Varricchio C: Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 277: 997-1003, 1997